Lisdexamfetamine dimesylate: A new therapeutic option for attention-deficit hyperactivity disorder

  1. Steer, C.
  2. Froelich, J.
  3. Soutullo, C.A.
  4. Johnson, M.
  5. Shaw, M.
Revue:
CNS Drugs

ISSN: 1172-7047,  1179-1934

Année de publication: 2012

Volumen: 26

Número: 8

Pages: 691-705

Type: Révision

DOI: 10.2165/11634340-000000000-00000 GOOGLE SCHOLAR
La source de données: Scopus